Approval · Notice of Compliance 9188 · 2007
NATRECOR: Notice of Compliance 9188
Issued November 8, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
Issued with conditions (NOC/c): the company must confirm the benefit in further studies.
- Notice number
- 9188
- Date
- November 8, 2007
- Company
- Janssen-Ortho Inc.
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Recombinant human B-type natriuretic peptide (rhbnp)
- With conditions
- Yes (NOC/c)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NATRECOR | 02301393 | Cancelled Post Market |
Medicinal ingredients
- NESIRITIDE 1.5 MG per VIAL